Skip to main content

US ClosedU.S. Closed

DRMA: Dermata Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.

52W Range

7thpctl

Volume

1.39×avg

Market Cap

913286USD

P/E Ratio

-0.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Dermata Therapeutics, Inc.

DRMANASDAQ Capital Market·USD·Closed

Dermata Therapeutics, Inc.

DRMANASDAQ·USD·Closed

$1.34

−8.22%

$1.34

−$0.12 (8.22%)

52W Range

7thpctl

Volume

1.39×avg

Mkt Cap

913286USD

P/E

-0.3TTM

Div Yield

–ann